期刊
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
卷 102, 期 4, 页码 477-487出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pbb.2012.06.009
关键词
Depression; Effort-related choice behavior; Parkinson's disease; Drug-induced parkinsonism; Locomotion; Tremulous jaw movements; c-Fos; DARPP-32
资金
- National Institute of Mental Health [MH078023]
- Conselleria de Empresa, Universitat i Ciencia
- Generalitat Valenciana [BEST/2009/157]
- BMBF, Germany in the frame of ERA-NET NEURON [01EW0911]
Adenosine A(2A) and dopamine D2 receptors interact to regulate diverse aspects of ventral and dorsal stliatal functions related to motivational and motor processes, and it has been suggested that adenosine Am antagonists could be useful for the treatment of depression, parkinsonism and other disorders. The present experiments were performed to characterize the effects of MSX-4, which is an amino acid ester prodrug of the potent and selective adenosine A(2A) receptor antagonist MSX-2, by assessing its ability to reverse pharmacologically induced motivational and motor impairments. In the first group of studies. MSX-4 reversed the effects of the D2 antagonist eticlopride on a concurrent lever pressing/chow feeding task that is used as a measure of effort-related choice behavior. MSX-4 was less potent after intraperitoneal administration than the comparison compound, MSX-3, though both were equally efficacious. With this task, MSX-4 was orally active in the same dose range as MSX-3. MSX-4 also reversed the locomotor suppression induced by eticlopride in the open field, but did not induce anxiogenic effects as measured by the relative amount of interior activity. Behaviorally active doses of MSX-4 also attenuated the increase in c-Fos and pDARPP-32(Thr34) expression in nucleus accumbens core that was induced by injections of eticlopride. In addition, MSX-4 suppressed the oral tremor induced by the anticholinesterase galantamine, which is consistent with an antiparkinsonian profile. These actions of MSX-4 indicate that this compound could have potential utility as a treatment for parkinsonism, as well as some of the motivational symptoms of depression and other disorders. (c) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据